KMT2D and adamantinoma: The application of WES and RNA sequencing (RNA‐Seq) on both tumor types resulted in the recurrent mutation of Lysine Methyltransferase 2D (KMT2D) gene in 38% of adamantinomas, indicating the potential role of chromatin structure and integrity in adamantinoma carcinogenesis.